SOLS Solstice Advanced Materials, Inc.
Solstice Advanced Materials, Inc. operates as a specialty chemicals and advanced materials company in the United States and internationally. It operates in two segments: Refrigerants & Applied Solutions (RAS), and Electronic & Specialty Materials (ESM). The RAS segment manufactures and sells low global warming potential (LGWP) refrigerants, blowing agents, solvents, and aerosol materials; and provides, aerosol propellants, cleaning solvents, pharmaceutical packaging materials, and alternative energy services under the Solstice, Genetron, and Aclar brands. The ESM segment offers electronic materials, fibers and laboratory life science chemicals for semiconductor, defense, pharmaceutical, and construction markets. This segment provides sputtering targets, lightweight high-strength fibers, and high-purity life science solutions under the Spectra, Fluka, and Hydranal brands. Solstice Advanced Materials, Inc. was incorporated in 2025 and is headquartered in Morris Plains, New Jersey.…
Industry Peers
Specialty ChemicalsKey Statistics
About Solstice Advanced Materials (NASDAQ: SOLS)
›
Solstice Advanced Materials (NASDAQ: SOLS) is listed on Nasdaq, where its shares trade in USD. It belongs to the Specialty Chemicals industry, part of the Basic Materials sector, and reports about 4,100 employees.
The shares were at 66.12 USD on 13 November 2026, up 41.3% over 52 weeks. Its 52-week range is 40.43 USD to 90.80 USD: the price is 27.2% below the high and 63.5% above the low.
At a market capitalisation of 10.39B USD, it trades at 32.4 times trailing earnings and 19.7 times forward earnings. The median trailing P/E of its 18 largest Specialty Chemicals peers is 34.8, so SOLS is valued in line with them. It pays a dividend yielding 0.45% (it pays out 11% of its earnings), against a median of 1.76% among the dividend payers in that peer group.
Solstice Advanced Materials reports return on equity of 16.8%, an operating margin of 17.2% and revenue up 7.9% year over year.
Its debt exceeds its cash by 1.70B USD, a debt-to-equity ratio of 1.77. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 10 analysts cover the stock, with an average rating of Buy; their mean price target of 77.90 USD is 17.8% above the current price. The next earnings report is expected on 10 February 2027.